Rezolute (RZLT) Change in Accured Expenses (2012 - 2026)
Rezolute (RZLT) reported Change in Accured Expenses of -$1.4 million for Q1 2026, up 60.66% on a YoY basis from -$883232.6 in Q1 2025, and down 2.23% sequentially from -$1.4 million in Q4 2025.
Rezolute (RZLT) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Rezolute (RZLT) has 15 years of Change in Accured Expenses data on file, last reported at -$1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 60.66% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$238000.0 (down 158.7% YoY), and the FY2025 full-year result was $721000.0, down 66.4% from the prior year.
- Change in Accured Expenses retreated to -$1.4 million in Q1 2026, from -$1.4 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.7 million in Q3 2023 to a low of -$3.6 million in Q1 2025.
- A 5-year average of $3058.8 and a median of -$42000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses slumped 275.0% in 2022 and jumped 6550.0% in 2023, its largest moves.
- Tracing RZLT's Change in Accured Expenses over 5 years: stood at $2.1 million in 2022, then tumbled by 125.74% to -$540000.0 in 2023, then jumped by 373.7% to $1.5 million in 2024, then sank by 193.91% to -$1.4 million in 2025, then retreated by 2.23% to -$1.4 million in 2026.
- Business Quant data shows RZLT's Change in Accured Expenses at -$1.4 million in Q1 2026, -$1.4 million in Q4 2025, and $667000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -16.74 Mn |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - | -1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | 667,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | -3.61 Mn |
| Mar 31, 2025 | -3.61 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 948,000.00 |
| Sep 30, 2024 | 948,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Dec 31, 2023 | -540,000.00 |
| Dec 31, 2023 | -540,000.00 |